Fitbit enjoyed a 10 % rise in its stock price Thursday after the company announced that it's partnering with Dexcom to make the latter firm's glucose monitoring technology compatible with its Ionic smartwatch device. (fortune.com)
In March, the latter firm submitted the CAR - T drug CTL019 for FDA approval. (fortune.com)
The latter firm will be responsible for marketing and distributing the Remicade biosimilar in America if it wins the FDA's blessing. (fortune.com)